Dublin, Dec. 11, 2023 /PRNewswire/ — The “3D Cell Culture and 3D Bioprinting Market Report 2023-2033” has been added to  ResearchAndMarkets.com’s offering.

World revenue for the 3D Cell Culture and 3D Bioprinting Market is forecast to surpass US$2.2 billion in 2023, with strong revenue growth through to 2033. 

The clinical applications of 3D cell culture and bioprinting technologies are burgeoning, heralding a new era of patient-centric healthcare solutions. Implantable tissues, artificial organs, and personalized grafts are poised to revolutionize surgical procedures, offering safer and more effective interventions. Moreover, these technologies hold immense potential for the study and treatment of a wide array of diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. With regulatory bodies becoming increasingly receptive to these innovative approaches, the market is primed for substantial growth in the clinical sector.

Beyond Healthcare and Pharmaceuticals

While healthcare and pharmaceutical industries are the primary drivers of the 3D cell culture and bioprinting market, ancillary sectors are also poised to reap substantial benefits. The cosmetics and skincare industry, for instance, is capitalizing on 3D skin models for efficacy testing, enabling the development of safer and more effective products. Additionally, the food and beverage sector is exploring the potential of 3D bioprinting in cultured meat production, offering a sustainable alternative to traditional livestock farming. This diversification of applications signifies a broader market reach and opens up new revenue streams for stakeholders.

Market Dynamics

Market Driving Factors

• Rising Demand for Drug Development
• 3D Bioprinting for Organ Transplanting
• Rising Stem Cell Research Driving Market Growth
• Use of 3D Cell Culture Model in Cancer Research

Market Restraining Factors

• Development of Complex Organ Structures
• Development of Realistic Vascular Networks
• High Cost and Operational Limitations of Bioprinters

Market Opportunities

• Development of Biocompatible and Printable Biomaterials
• Rising Commercialization and Mass Production in 3D Bioprinting
• Increase in New Product Launches and Collaborations to Offer Lucrative Growth Opportunities
• Use of Artificial Intelligence in 3D Bioprinting

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, this new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Technology

• Scaffold-based
• Scaffold-free
• Microfluidics-based
• Magnetic Levitation
• 3D Bioprinting
• Others

Application

• Cancer and Stem Cell Research
• Drug Discovery and Toxicology Testing
• Tissue Engineering and Regenerative Medicine

End-users

• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Research Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets.

The report also includes profiles and for some of the leading companies in the 3D Cell Culture and 3D Bioprinting Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• Aspect Biosystems
• CELLINK
• CN Bio Innovations
• Corning Incorporated
• CYFUSE BIOMEDICAL
• GeSiM
• InSphero
• Lonza
• Merck
• Organovo Holdings
• REPROCELL 
• Thermo Fisher Scientific
• ENVISIONTEC

In summary, the report provides you with the following knowledge:

• Revenue forecasts to 2033 for 3D Cell Culture and 3D Bioprinting Market 2023 to 2033, with forecasts for technology, application, and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 22 key national markets – See forecasts for the 3D Cell Culture and 3D Bioprinting Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 13 of the major companies involved in the 3D Cell Culture and 3D Bioprinting Market, 2023 to 2033.

For more information about this report visit https://www.researchandmarkets.com/r/mp8cvm

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/3d-cell-culture-and-3d-bioprinting-market-report-2023-2033—bridging-the-gap-between-bench-and-bedside-302011447.html

SOURCE Research and Markets